| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $984K | — | -13.4% |
| Cost of Revenue | $698K | — | -45.1% |
| Gross Profit | $285K | — | +309.8% |
| R&D Expense | $84K | — | +183.1% |
| SG&A Expense | $1.2M | — | +141.8% |
| Operating Income | -$1.1M | — | -47.3% |
| Interest Expense | $9K | — | +33.9% |
| Pre-tax Income | -$1.1M | — | -45.5% |
| Net Income | -$1.1M | — | -45.5% |
| EPS (Basic) | -$0.04 | — | +83.3% |
| EPS (Diluted) | -$0.04 | — | +83.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $168K | -51.2% | -57.9% |
| Accounts Receivable | $196K | -18.7% | -40.3% |
| Inventory | $1.5M | -7.6% | -24.3% |
| Current Assets | $2.0M | -14.6% | -29.7% |
| Total Assets | $45.1M | +45.6% | +217.5% |
| Current Liabilities | $7.3M | -1.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$55K | — | +4.4% |
| Capital Expenditures | $58K | — | +0.0% |
| Investing Cash Flow | -$58K | — | +28.0% |
| Financing Cash Flow | -$79K | — | -13.3% |
| Free Cash Flow | -$114K | — | +2.2% |
| +41.9% |
| Total Liabilities | $8.1M | -1.7% | +12.0% |
| Stockholders' Equity | $37.0M | +62.8% | +431.2% |